RecallDepth
Class I Terminated

Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled Pens per carton (NDC 49502-0196-75), Rx only, Manufactured in Malaysia for: Mylan Specialty L.P., Morgantown, WV, 26505.

This recall has been terminated (originally issued January 26, 2022).

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
January 5, 2022
Posted
January 26, 2022
Recall Number
D-0462-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
73,175 prefilled pens
Firm Location
Morgantown, WV, United States
Official Source
View on FDA website ↗

Reason for Recall

Labeling: Missing Label: label missing from some Semglee prefilled pens.

Distribution

Nationwide in the USA and Thailand.

Lot / Code Info

Batch # BF20003118, Exp. August 2022

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class I Drug recalls